These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 35506665)

  • 21. Engineering tumor-specific catalytic nanosystem for NIR-II photothermal-augmented and synergistic starvation/chemodynamic nanotherapy.
    Zhou S; Xu J; Dai Y; Wei Y; Chen L; Feng W; Chen Y; Ni X
    Biomater Res; 2022 Nov; 26(1):66. PubMed ID: 36435848
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recent Advances on NIR-II Light-Enhanced Chemodynamic Therapy.
    Wu GL; Tan X; Yang Q
    Adv Healthc Mater; 2024 Apr; 13(10):e2303451. PubMed ID: 37983596
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dual-Stimuli Responsive Bismuth Nanoraspberries for Multimodal Imaging and Combined Cancer Therapy.
    Li Z; Hu Y; Miao Z; Xu H; Li C; Zhao Y; Li Z; Chang M; Ma Z; Sun Y; Besenbacher F; Huang P; Yu M
    Nano Lett; 2018 Nov; 18(11):6778-6788. PubMed ID: 30288978
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Integration of Fe
    Luo K; Zhao J; Jia C; Chen Y; Zhang Z; Zhang J; Huang M; Wang S
    ACS Appl Mater Interfaces; 2020 May; 12(20):22650-22660. PubMed ID: 32330380
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mitochondria-Targeting MoS
    Li X; Xiao H; Xiu W; Yang K; Zhang Y; Yuwen L; Yang D; Weng L; Wang L
    ACS Appl Mater Interfaces; 2021 Dec; 13(47):55928-55938. PubMed ID: 34786942
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improving the photothermal therapy efficacy and preventing the surface oxidation of bismuth nanoparticles through the formation of a bismuth@bismuth selenide heterostructure.
    Li B; Cheng Y; Zheng R; Wu X; Qi F; Wu Y; Hu Y; Li X
    J Mater Chem B; 2020 Oct; 8(38):8803-8808. PubMed ID: 32857100
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chiral Cu
    Liu Y; Li H; Li S; Zhang X; Xiong J; Jiang F; Liu Y; Jiang P
    ACS Appl Mater Interfaces; 2021 Dec; 13(51):60933-60944. PubMed ID: 34923825
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A tumor-targeted theranostic nanomedicine with strong absorption in the NIR-II biowindow for image-guided multi-gradient therapy.
    Chen Q; Zheng Z; He X; Rong S; Qin Y; Peng X; Zhang R
    J Mater Chem B; 2020 Oct; 8(41):9492-9501. PubMed ID: 33001118
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Engineering Cu
    Du K; Zhao S; Feng J; Gao X; Liu K; Wang X; Zhang M; Li Y; Lu Y; Zhang H
    J Mater Chem B; 2021 Sep; 9(35):7216-7228. PubMed ID: 35226035
    [TBL] [Abstract][Full Text] [Related]  

  • 30. All-in-One Theranostic Nanomedicine with Ultrabright Second Near-Infrared Emission for Tumor-Modulated Bioimaging and Chemodynamic/Photodynamic Therapy.
    Xu J; Shi R; Chen G; Dong S; Yang P; Zhang Z; Niu N; Gai S; He F; Fu Y; Lin J
    ACS Nano; 2020 Aug; 14(8):9613-9625. PubMed ID: 32806021
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Second near-infrared photoactivatable nanomedicines for enhanced photothermal-chemodynamic therapy of cancer.
    Wu S; Liu C; Li W; Zhang C; Chen D; Xu C; Su L; Wang X
    J Mater Chem B; 2023 Mar; 11(11):2455-2465. PubMed ID: 36810638
    [TBL] [Abstract][Full Text] [Related]  

  • 32. H
    Xiao Z; Zuo W; Chen L; Wu L; Liu N; Liu J; Jin Q; Zhao Y; Zhu X
    ACS Appl Mater Interfaces; 2021 Sep; 13(37):43925-43936. PubMed ID: 34499485
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NIR-II-driven and glutathione depletion-enhanced hypoxia-irrelevant free radical nanogenerator for combined cancer therapy.
    Zhang L; Fan Y; Yang Z; Yang M; Wong CY
    J Nanobiotechnology; 2021 Sep; 19(1):265. PubMed ID: 34488803
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ultrasmall Cu
    Hu R; Fang Y; Huo M; Yao H; Wang C; Chen Y; Wu R
    Biomaterials; 2019 Jun; 206():101-114. PubMed ID: 30927714
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Precisely NIR-II-activated and pH-responsive cascade catalytic nanoreactor for controlled drug release and self-enhanced synergetic therapy.
    Hu P; Zhao S; Shi J; Li F; Wang S; Gan Y; Liu L; Yu S
    Nanoscale; 2022 Sep; 14(34):12219-12231. PubMed ID: 35582977
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ultrasmall Semimetal Nanoparticles of Bismuth for Dual-Modal Computed Tomography/Photoacoustic Imaging and Synergistic Thermoradiotherapy.
    Yu X; Li A; Zhao C; Yang K; Chen X; Li W
    ACS Nano; 2017 Apr; 11(4):3990-4001. PubMed ID: 28395135
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis of Bi
    Wang S; Wang H; Song C; Li Z; Wang Z; Xu H; Yu W; Peng C; Li M; Chen Z
    Nanoscale; 2019 Aug; 11(32):15326-15338. PubMed ID: 31386732
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Photonic cancer nanomedicine using the near infrared-II biowindow enabled by biocompatible titanium nitride nanoplatforms.
    Wang C; Dai C; Hu Z; Li H; Yu L; Lin H; Bai J; Chen Y
    Nanoscale Horiz; 2019 Mar; 4(2):415-425. PubMed ID: 32254094
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Doxorubicin-loaded hydrogen peroxide self-providing copper nanodots for combination of chemotherapy and acid-induced chemodynamic therapy against breast cancer.
    Li JX; Zhang LM; Liu CC; Wu QN; Li SP; Lei XP; Huang YG; Feng GN; Yu XY; Sun XQ; Guo ZM; Fu JJ
    J Colloid Interface Sci; 2021 Jul; 593():323-334. PubMed ID: 33744541
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transcatheter Intra-Arterial Infusion Combined with Interventional Photothermal Therapy for the Treatment of Hepatocellular Carcinoma.
    Zhou J; Ling G; Cao J; Ding X; Liao X; Wu M; Zhou X; Xu H; Long Q
    Int J Nanomedicine; 2020; 15():1373-1385. PubMed ID: 32184592
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.